Gottesdiener Keith Michael 4
4 · Prime Medicine, Inc. · Filed Dec 9, 2024
Insider Transaction Report
Form 4
Gottesdiener Keith Michael
DirectorSee Remarks
Transactions
- Award
Stock Option (right to buy)
2024-12-05+100,000→ 200,000 totalExercise: $8.32Exp: 2034-02-25→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Represents an option initially granted to the Reporting Person on February 25, 2024, a portion of which shares underlying this option shall vest on February 25, 2025 upon the achievement of certain performance milestones. On December 5, 2024, the board of directors of the Issuer determined that one of the performance milestone conditions was achieved. As a result, the shares underlying this option shall vest on February 25, 2025, subject to the Reporting Person's continued service through such vesting date.